ArticleClinical kidney journal2025
Global burden and trends of stroke attributable to kidney dysfunction from 1990 to 2021.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring the stroke burden linked to Kidney dysfunction: trends, predictive insights, and health inequalities.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accumulating evidence suggests that kidney dysfunction (KD) is a risk factor for stroke and stroke subtypes (SSS). However, comprehensive studies on the global burden of SSS attributable to KD are lacking. This study aimed to compare the long-term trends of KD-related SSS from 1990 to 2021 at the global, regional and national levels, and predict the disease burden until 2045. Methods: The dataset was collected from the 2021 Global Burden of Disease Study (GBD). The study estimated mortality and disability-adjusted life years (DALYs) counts, while also calculating estimated annual percentage changes (EAPCs) to evaluate long-term trends in age-standardized rates of mortality and DALYs. The analyses were stratified based on sex, 14 age categories, 5 socio-demographic index (SDI) quintiles, 21 GBD regions, and 204 nations and territories. Statistical analyses and visualizations were conducted using R version 4.4.2. Results: Between 1990 and 2021, KD-related stroke mortality rose by 40.4%, and DALYs were increased by 36.7%, with EAPCs of -1.8 and -1.7, respectively. KD-related ischaemic stroke mortality and DALYs grew by 45.9% and 47.4%, with EAPCs of -1.9 and -1.7. KD-related intracerebral haemorrhage mortality and DALYs increased by 35.3% and 28.7%, with EAPCs of -1.7 and -1.7. There was notable variation by sex and age. The major burden was located in the middle SDI region and East Asia (especially in China). Decomposition analyses revealed an increase burden in total KD-related SSS, with a positive contribution from population growth and aging. The burden of KD-related SSS has steadily risen and is expected to keep growing until 2045. Conclusion: Despite a slight decrease in long-term trends, this study highlights a significant rise in the global burden of KD-related SSS, with notable variations across SDI areas, GBD regions, countries, sexes and age groups. This increasing challenge necessitates specific therapies and public health initiatives for KD-related SSS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.